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Abstract 
 
Worldwide, the food-born pathogen Campylobac-
ter jejuni is the leading bacterial source of human 
gastroenteritis. C. jejuni produces a variety of di-
verse cell-surface carbohydrates that are essential 
for pathogenicity. A critical component of these ol-
igo- and polysaccharides is the sugar N-acetylgalac-
tosamine (GalNAc). The sole source of this sugar is 
the epimerization of UDP-N-acetylglucosamine 
(GlcNAc), a reaction catalyzed by the enzyme 
UDP-GlcNAc 4-epimerase (Gne). This enzyme is 
unique among known bacterial epimerases in that it 
also catalyzes the equivalent reaction with the non-
N-acetylated sugars. Understanding how CjGne 
catalyzes these various interconversions is critical 
to designing novel inhibitors of this enzyme. Here, 
to further the mechanistic understanding we present 
a 2.0Å structure of CjGne with its NAD+ co-factor 
bound. Based on novel features found in the struc-
ture we perform a variety of biochemical studies to 
probe the mechanism and compare these results to 
another bifunctional epimerase, human GalE. We 
further show that ebselen, previously identified for 
inhibition of HsGalE, is active against CjGne, sug-
gesting a route for antibiotic development. 
 
 
Introduction 
  
Campylobacter jejuni, a microaerophilic pathogen, 
is a commensal of chickens and other avians and the 
most prevalent member of the Campylobacter spp., 
which are the leading causes of bacterial gastroen-
teritis worldwide (1, 2). It can be associated with 
post-infectious sequelae include Guillain-Barrè 
syndrome (3), bacteremia (4), and reactive arthritis 
(5). The C. jejuni glycome contains a number of 
surface-accessible carbohydrate structures required 
for interactions with the various hosts that include 
capsular polysaccharide (CPS), lipooligosaccharide 
(LOS), and N- and O-linked glycans (6–12). Varia-
bility in the nature of the surface glycans challenges 
the development of anti-Campylobacter therapies 
(13, 14). 
 
All of the exposed currently identified glycans in C. 
jejuni contain a GalNAc residue (14–17), which is 
only produced through the epimerization of Glc-
NAc by the enzyme encoded by the gene gne 
(UDP-GlcNAc 4-epimerase). It was recently rean-
notated from galE (UDP-Gal 4-epimerase) due to 
the discovery of the UDP-GlcNAc epimerization 
activity (16) (Figure 1A). In the C. jejuni genome 
(strain NCTC11168), this gene is located between 
the gene clusters of the N-linked glycosylation and 
LOS biosynthesis pathways (18). The gene in C. je-
juni was first believed to be involved in the LPS bi-
osynthesis pathway (10), but later its functional role 
in N-linked glycosylation was elucidated (19, 20). 
Furthermore, the experiments with an insertional 
mutant of gne indicated that it is responsible for 
providing GalNAc residues to the three major cell-
surface glycoconjugates (16). The bifunctional pro-
tein CjGne represents a potential therapeutic target 
as most oligosaccharides in C. jejuni, which contain 
a GalNAc residue, are required for pathogenesis 
(21). A mechanistic understanding is key to devel-
oping therapeutics that target this unusual epi-
merase. 
 
UDP-hexose 4-epimerases, including CjGne, be-
long to a protein family of short-chain dehydrogen-
ases/reductases (SDRs) (22). SDR enzymes possess 
diverse substrate specificity (23), as seen in the 
UDP-hexose 4-epimerases that have undergone de-
tailed characterization (24). Structures of UDP-
hexose 4-epimerases are available from all three 
domains of life: GalE from Escherichia coli 
(EcGalE) (25–27), GalE from Trypanosoma brucei 
(TbGalE) (28), GalE from Pyrobaculum calidifon-
tis (PcGalE) (29), GalE from Homo sapiens 
(HsGalE) (30, 31), GalE from Thermotoga mari-
tima (TmGalE) (32), WbpP from Pseudomonas ae-
ruginosa (PaWbpP) (33), and WbgU from Plesio-
monas shigelloids (PsWbgU) (34). A classification 
scheme has been proposed for substrate preference 
of the UDP-hexose 4-epimerases (33). The scheme 
categorizes the epimerases in three different groups 
depending on the side chain size of six key active 
site residues. Group 1 epimerases, such as EcGalE 
and TbGalE, interconvert only the non-acetylated 
moieties, UDP-Glc and UDP-Gal. Group 3 en-
zymes prefer epimerizing acetylated moieties and 
the examples are PaWbpP and PsWbgU. Group 2 
members include CjGne and HsGalE with no pref-
erence for interconversion of the non-acetylated or 
acetylated UDP-hexoses. All of the UDP-hexose 4-
epimerases structurally characterized so far are 
functional either in the Leloir pathway for galactose 
metabolism or the LPS O-antigen biosynthesis 
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pathway. No epimerase known to act on multiple 
pathways has yet been a subject of structural stud-
ies.  
 
Toward a mechanistic understanding of this bi-
functional multi-pathway enzyme, here we provide 
a 2.0Å crystal structure of NAD+-bound CjGne. 
Structural characteristics of CjGne that are common 
or distinct to its homologs are discussed. Based on 
the structural features and the epimerization results 
of the wild type and its mutants, we propose some 
critical residues of CjGne that are catalytically or 
structurally important for shaping its substrate-
binding site and determining substrate specificity.  
  
 
Results 
 
The overall architecture of CjGne bound with 
NAD+  
 
The gene for CjGne was cloned into an expression 
vector, induced in E. coli, purified by chromatog-
raphy, and crystallized via conditions initially ob-
tained through standard screens. Crystals diffracted 
to 2.0Å and a complete data set was collected. Data 
were processed using standard tools and the struc-
ture was solved by molecular replacement using 
BaGalE (PDB entry: 2C20). The fully refined 
model contained a dimer of CjGne with an R-factor 
of 19.5% and an Rfree of 22.5%. A complete atomic 
model containing residues 2-328 was attained for 
each with an RMSD of 0.38 Å between the two cop-
ies. Crystallographic statistics are found in Table 1. 
The two copies in the asymmetric unit are related 
by a two-fold rotational axis (Figure 1B). Con-
sistent with this as a dimer interface, in solution the 
enzyme purified as a dimer which was verified us-
ing SEC-MALLS. The apparent molecular weight 
of 72 kDa was comparable to a dimer of 74 kDa 
(Figure 1C). For clarity, subunit A (indicated in 
Figure 1B) will be used in figures when only one is 
present. 
 
The general structure of CjGne is consistent with 
that seen for related epimerases with a Glycosyl-
transferase A fold. Each subunit of CjGne contains 
two domains and one NAD+ cofactor (Figure 1D). 
The domain that contains the N-terminus (M1-
Y174, I230-H260, I295-D312) is composed of a 
central, twisted, parallel, seven–stranded, β–sheet 
flanked on each side by four α-helices. This domain 
resembles a ‘Rossmann-fold’ motif where the 
NAD+ binds that is common to SDR enzymes (35) 
and will be referred to as the NAD-binding domain 
(NBD). The substrate-binding domain (SBD) con-
taining mostly C-terminal residues (F175-F229, 
G261-L294, D313-C328) is composed of three a-
helices and two parallel b-strands. Previous struc-
tural studies of related epimerases demonstrate that 
the UDP-hexose substrate resides in the cleft be-
tween the two domains with the UDP moiety pri-
marily contacting the SBD (26).  
 
The conserved NAD-binding domain (NBD) 
 
Both NAD+ and NADH have been previously re-
solved in crystal structures of related epimerases 
(27). The only structural difference between NAD+ 
and NADH is in the nicotinamide ring (Figure 2A). 
At this resolution, analyzing the 2Fo-Fc map 
around the nicotinamide ring did not conclusively 
demonstrate whether or not the ring is planar (Fig-
ure 2B). We instead compared Fo-Fc maps after re-
fining the data with the model of NAD+ and NADH. 
When NADH was used in refinement an additional 
positive density in the Fo-Fc map appeared in the 
nicotinamide ring; no density was seen for NAD+ 
(Figure 2B). The unaccounted-for electron density 
with NADH is consistent with the additional elec-
trons found in the nicotinamide ring of NAD+, 
which we conclude is the major state in our crystal 
form. The nicotinamide ring adopts the syn confor-
mation with respect to the ribose as seen in some of 
the EcGalE (PDB ID: 1NAI, 1XEL, 1LRL) and all 
of the HsGalE structures (PDB ID: 1EK5, 1EK6, 
1HZJ) published. However, it is unclear whether 
there is any correlation between the identity and 
conformation of this cofactor in the NAD-binding 
domain and substrate identity.  
 
The interaction with NAD+ seen here is character-
istic of related NAD-binding domains. The details 
were first described in the structure of GalE from E. 
coli where a series of conserved residues line the 
binding pocket (PDB ID: 1NAI) (36). In CjGne, 
Ser34 and Lys35 forms one more and one less hy-
drogen bond than the corresponding residues in 
EcGalE, respectively (Figure 2C). In EcGalE, an 
additional residue Lys84 stabilizes the pyrophos-
phate group of NAD+ via two hydrogen bonds, 
while the corresponding residue Ile82 in CjGne 
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makes none (Figure 2C). Overall, seven residues 
(Asp31, Asn21, Ser34, Lys35, Asp56, Leu57, 
Asn97) are in hydrogen-bonding distance with the 
adenosine of NAD+. Two residues (Tyr11, Ile12) 
and four residues (Phe78, Tyr146, Lys150, Tyr174) 
are interacting through hydrogen bonds with the py-
rophosphate group and nicotinamide/ribose of 
NAD+, respectively.  
 
Apo-substrate-binding pocket is expanded  
 
In a comparison to the other bifunctional epimerase 
HsGalE, our apo-CjGne structure aligns best with 
the available apo-GalE ‘resting enzyme’ from hu-
man (PDB ID: 1EK5) (30) with an RMSD of 1.292 
Å. The SBDs alone align with the RMSD value is 
1.224 Å, similar to the overall RMSD. In order to 
find differences in the substrate-binding sites, 
CjGne was aligned only with the SBD of HsGalE 
bound to UDP-GlcNAc (PDB ID: 1HZJ) (Figure 
3A). Based on the superposition location of the sub-
strate, while R300 and D303 of HsGalE stabilize 
UDP-GlcNAc through some hydrogen bonds (Fig-
ure 3B), the corresponding residues (R287 and 
D290) of CjGne are unlikely to contact the UDP-
GlcNAc (Figure 3C). Instead, D290 forms a hydro-
gen bond with R287, which in turn interacts with 
the backbone of Y190 and P191 (Figure 3C and 3D). 
Interestingly, Y190 and P191 are part of the shifted 
loop in CjGne that will be described in the next sec-
tion.  
 
A shifted loop in the CjGne structure  
 
Our crystal structure of CjGne revealed a surprising 
feature not found in any other structures of its re-
lated enzymes. In CjGne, one loop region (174-YF-
NAGACMDYTLGQRYPKATL-195) is shifted to-
ward the NBD obstructing the substrate-binding 
pocket (Figure 4A). In the crystal, this shift is 
locked by a disulfide bond between C181 and the 
C-terminal residue, C328 (Figure 4A). Both of 
these cysteine residues are not found in related epi-
merases, except for closely related Campylobacter 
spp where they always occur as a pair (Figure 4B, 
4C, and 4D). We presume disulfide bond formation 
results in stabilization of the shifted loop. CjGne lo-
calizes in the cytoplasm and, under typical media 
conditions, this would be a reducing environment 
incompatible with a disulfide bond. During purifi-
cation fresh DTT was added to all buffers (pH 7.5) 
to maintain a reducing environment. However, the 
presence of the disulfide suggested this was insuf-
ficient. DTT is reported to be readily oxidized 
above pH 7.5 (37) and in the presence of metal ions 
like Ni2+ contaminants from Ni column (38). TCEP 
was added as an alternative to the final protein so-
lution and incubated overnight before setting up 
crystal trays. It was also added to cryo-protecting 
conditions when harvesting crystals. Although 
TCEP is known to be stable at both acidic and basic 
conditions (37) and active with some metal contam-
inants, all acquired crystals had the disulfide bond. 
This suggests that the formation of the disulfide is 
favored by the protein. 
 
The internal cysteine forming the disulfide bond 
is important for activity  
 
We first examined the CjGne-catalyzed percent 
conversion of the four substrates (UDP-Glc, UDP-
Gal, UDP-GlcNAc, and UDP-GalNAc) at equilib-
rium using capillary electrophoresis (CE). When 
the sample reaction started from either UDP-Glc or 
UDP-Gal, the ratio for the integral areas reached 
23:75 (UDP-Glc:UDP-Gal) at equilibrium irrespec-
tive of the starting substrate (Figure 5A, 5B, and 
Table 2). Similarly, in the presence of either UDP-
GlcNAc or UDP-GalNAc as a substrate, the reac-
tions reached the ratio of 28:71 (UDP-Glc-
NAc:UDP-GalNAc) at equilibrium (Figure 5A, 5B, 
and Table 2). With this assay we confirmed the bi-
functional activity of CjGne in interconverting sim-
ilar amounts of non-acetylated and acetylated sub-
strates. 
 
The unexpected disulfide bond brings into question 
whether there may be biological importance to 
these residues. To examine the roles of C181 and 
C328, we expressed and purified various cysteine 
mutants (C181A, C181S, C328S, ΔC328, and 
C181S/ΔC328) and analyzed their activities at 
equilibrium (Figure 5C and Table 2). All of the 
C181 mutants (C181A, C181S, and C181S/ΔC328) 
resulted in significant loss of activity, less than 20% 
of wild type conversion, irrespective of the starting 
UDP-hexose. For the C-terminal cysteine, the 
C328S mutant lost more than 50% of the wild-type 
conversion. Yet surprisingly, the deletion of C-ter-
minal C328 retained the full activity of the wild 
type regardless of the substrate added.  
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The similar HsGalE cysteine is not required for 
activity  
 
In the multiple sequence alignment of CjGne and its 
homologs (Figure 4E), there is no epimerase that 
has a cysteine residue at the corresponding position 
to C181 of CjGne. Instead, the human epimerase 
among the homologs is the only example that has a 
cysteine residue (C196) within the corresponding 
loop region (Y185-N207) to the previously men-
tioned loop (Y174-L195) in CjGne. We expressed 
and purified the C196A and C196S mutants of 
HsGalE and investigated their epimerization activ-
ity at equilibrium in the reaction with each of the 
sugar substrates. Again, we confirmed the bifunc-
tional nature of the enzyme. In this case, both mu-
tants had no significant loss in activity relative to 
the wild type (Figure 5C and Table 2).  
 
The CjGne internal cysteine is important in ther-
mal stability of the enzyme  
 
Thermal denaturation of the wild-type CjGne and 
its cysteine mutants was monitored through melting 
curves and calculated melting temperature (Tm) 
(Figure 5D and Table 3). The Tm values across the 
four UDP-hexose substrates within an enzyme 
stayed the same or had a difference of less than 1°C. 
All the cysteine mutants of CjGne had Tm values 
that are lower than the wild type by 1°C or more. 
The single and double mutants containing C181A 
decreased the Tm values the most by 8°C. Protein 
unfolding was also monitored for the HsGalE C196 
mutants (Figure 5D and Table 3). Unlike those of 
the CjGne mutants, the Tm values did not change. 
 
Critical residues of CjGne for substrate binding 
and specificity  
 
We performed a structural alignment between 
CjGne and HsGalE bound with UDP-GlcNAc 
(PDB ID: 1HZJ) (Figure 6A). From the alignment, 
we identified five residues of CjGne that can make 
polar contacts with the UDP-GlcNAc (T122, N176, 
P185, K192, and T194). Among them, both T122, 
either a serine or threonine, and N176 is conserved 
among the homologous sequences (Figure 4E and 
Supplementary Figure 1). In order to examine their 
functional roles within the predicted active site, we 
introduced mutations that retain the size, but lose 
polarity of the side chain: T122V and N176L (Fig-
ure 6A). 
 
Based on the classification scheme for UDP-hexose 
4-epimerases (33), the T122 and N176 residues are 
two of the six key residues in CjGne, determining 
substrate specificity. Another key residue, L294, 
was also subject to mutation varying the size of hy-
drophobic side chains (valine, methionine, and ty-
rosine) to investigate its role in substrate specificity 
(Figure 6A). The corresponding residue of L294 in 
EcGalE (Y299) was the first example that showed 
a single-residue mutation at this position to cysteine 
altered substrate specificity (39).  
 
The equilibrium assay was then performed with 
each of the mutants. For T122V and N176L, there 
was nearly a complete loss of conversion for all of 
the four UDP-sugar substrates (Figure 6B). This 
supports that T122 and N176 have catalytic roles 
that are essential for the epimerization activity of 
CjGne. T122 of CjGne is structurally aligned to 
S124 (EcGalE), which is suggested to mediate ca-
talysis by being hydrogen-bonded to Y149 
(EcGalE), an active site base, and to the 4’-hy-
droxyl group of the glucosyl ring of UDP-Glc (40). 
Also, in HsGalE, the corresponding residue, S132 
interacts with the 4’-OH group of hexose. In CjGne, 
T122 and Y146 (Y149 in EcGalE) are not in hydro-
gen-bonding distance.  
 
N179 of EcGalE, N176 in CjGne, has been sug-
gested as one of the amino acid residues that contact 
the hexose portion of UDP-Glc/Gal within a hydro-
gen-bonding distance and thereby important for 
binding of the substrate in the E. coli (27). CjGne 
N176 is in hydrogen bonding distance of the mod-
eled UDP-GlcNAc (Figure 6A). Alternatively, the 
amino group of N187 (HsGalE) interacts directly 
with the two phosphoryl oxygen atoms of the β-
phosphate group of the nucleotide. With substrate 
bound N176 may re-orient in CjGne to make this 
same interaction. 
 
The epimerization assay was also performed for the 
L294V, L294M, and L294Y mutants to investigate 
if the size of the L294 side chain alters substrate 
specificity of CjGne (Figure 6B). None of the mu-
tants retained activities at a comparable level to 
those of the wild type with all four substrates. How-
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ever, among the mutants L294V had the least dis-
ruption for interconversion of non-acetylated sub-
strates, whereas L294M had the highest activity for 
acetylated substrates.  
 
Ebselen inhibiting HsGalE is a potential inhibi-
tor of CjGne  
 
Few studies have reported inhibitors of GalE, and 
none of them are promising for further drug devel-
opment. One report identified ebselen, an orga-
noselenium compound, inhibition of HsGalE with 
nanomolar IC50 (0.014 µM) (41). Since CjGne pos-
sesses a bifunctional activity just like HsGalE, we 
predicted that the inhibitors that are potent to 
HsGalE would also exert inhibitory effect on 
CjGne. An inhibition assay of CjGne using capil-
lary electrophoresis was performed in the presence 
of ebselen (Figure 7). Indeed, the inhibition was al-
most complete when ebselen was incubated with 
the enzyme with either UDP-Gal or UDP-GalNAc, 
while slightly less inhibition for UDP-Glc or UDP-
GlcNAc as initial substrates (13% and 22% of the 
wild-type activity was retained, respectively). 
 
 
Discussion 
 
In this study, we provide the first structure and bio-
chemically characterize CjGne, a bifunctional 
UDP-Glc/GlcNAc 4-epimerase, the sole enzyme 
producing the GalNAc residue for the major surface 
polysaccharides in C. jejuni. Gne is functionally 
separated from other forementioned UDP-Glc/Glc-
NAc 4-epimerases that either work in the Leloir 
pathway for galactose metabolism or are part of the 
LPS biosynthesis pathway.  
 
A surprising result is the presence of a structural di-
sulfide bond in CjGne. Expressed heterologously in 
the E. coli system, in the cytosol one expects these 
cysteines to be reduced (42). Other exceptions have 
been reported where structural disulfides in cyto-
solic proteins of thermophilic archaeal species pro-
tect them from denaturation at high temperature 
(43). C. jejuni is a moderate thermophilic species 
thriving at 37-42°C (44) with a Tm for CjGne at 
57°C (Figure 5D and Table 3). The presence of a 
structural disulfide bond might help CjGne tolerate 
growing at higher temperature.  
 
The cysteine at position 181 is not conserved (Fig-
ure 4E), yet replacing C181 with either alanine or 
serine led to a loss of activity. In the structure, a 
water mediated network connects the phosphate 
groups of the substrate to the backbone of the C181 
residue. These are unlikely to be disrupted by the 
simple mutations. When the other half of the disul-
fide pair, C328, was replaced with a serine, less 
than 50% wild-type conversion was retained. Sur-
prisingly, deletion of the C-terminal cysteine (C328) 
was fully active. In total, we can conclude that the 
disulfide bond is not required for the catalysis. 
However, the cysteines are important for full activ-
ity. Cysteines often make hydrophobic contacts and 
the effects from the loss of the spatial hydrophobic 
environment may provide rationale for the reduc-
tion in activity upon mutation to serine. Supporting 
this, all the cysteine mutants of CjGne reduced the 
overall stability of the protein (Figure 5D and Table 
3). This suggests general structural roles that could 
affect catalysis.  
 
A major feature of our CjGne structure is the shift 
of the loop region (Y174-L195) toward the active 
site in CjGne. The presence of the disulfide sug-
gests that this may fix the conformation of the loop. 
The sequence of this region is conserved across 
other Campylobacter species and the electron den-
sity shows the conformation is well ordered. In this 
conformation, the protein would be expected to be 
inhibited. We can speculate on a biological role for 
this cysteine mediated shift. It had previously been 
shown that the mucosal defense of the release of re-
active oxygen species led to inactivation of CjGne 
lowering virulence and altering surface polysaccha-
rides (45). Here it was shown also that an important 
population of CjGne localized to the outer mem-
brane. C. jejuni regulates cell envelope genes, in-
cluding Gne, during infection (46). These various 
points support that Gne function might be modu-
lated as a response to various cellular environments, 
perhaps to facilitate infection under stress condi-
tions. 
 
While the cysteines are important for functional 
protein in C. jejuni, a related cysteine in the func-
tional homolog HsGalE was not required for full ac-
tivity. In the structure of the human there is no shift 
of the corresponding CjGne loop (Y174-L195). 
This lends credence to the importance of these res-
idues in the C. jejuni enzyme. 
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The mechanism of this class of epimerases has been 
elucidated over time; however, there remain some 
details to be resolved. We chose candidate residues 
that are predicted to be critical in substrate binding 
or specificity from the structural and sequence 
alignments with the human epimerase in complex 
with NADH and UDP-GlcNAc (PDB entry: 1HZJ). 
Both the T122V and N176L mutants lost activity 
irrespective of the substrate tested. This result is in-
dicative of catalytic importance of the residues. The 
highly conserved serine residues of the other hom-
ologs aligned with T122 of CjGne have been shown 
to play a role in mediating the electron transfer dur-
ing the catalytic mechanism. The asparagine resi-
due corresponding to N176 in CjGne is also almost 
perfectly conserved across species. The N195 resi-
due in the PsWbgU (N176; CjGne), for example, 
forms two hydrogen bonds via the carbonyl oxygen 
and the amine group with the NH-group and the ox-
ybridge of the diphospho moiety of UDP-GlcNAc, 
respectively. Based on the high conservation and 
previous functional characterization in other homo-
logs, T122 and N176 of CjGne are likely to require 
polar side chains to be either directly or indirectly 
involved in catalysis and to interact with the sub-
strate bound, respectively.  
 
L294 of CjGne was chosen for mutagenesis studies 
because it had previously been shown for homologs 
that mutations at this position altered substrate 
specificity. Previous studies demonstrated that 
Y299C of EcGalE (47) allowed conversion of acet-
ylated substrates, while C307Y of HsGalE (48) and 
S306Y of EcGalEO86:B7 (49) lost the conversion ac-
tivity of acetylated substrates. In contrast, mutation 
of the corresponding residue from PaWbpP 
(S317Y) resulted in complete loss of activity, so no 
further insights regarding side chain size of this res-
idue for substrate specificity was available (33). We 
mutated the residue in the same position, L294, of 
CjGne into valine, methionine, and tyrosine to see 
if various sizes of hydrophobic side chains can af-
fect the activities of any UDP-hexose substrate. We 
predicted that L294M would retain bifunctionality, 
whereas L294V and L294Y would preferentially 
convert the acetylated and non-acetylated sugar 
substrates, respectively. None of the three mutants 
of L294 retained the full activities of the wild type, 
but showed similar levels of reduction between 
UDP-Glc and UDP-Gal and generally more reduc-
tion with UDP-GalNAc. Approximately 50% re-
duction in L294V activity with non-acetylated sub-
strates can be explained by the smaller hydrophobic 
side chain of valine that increased the active site 
volume, rendering the binding to non-acetylated 
and/or acetylated substrates less specific. Also, the 
hydrophobic interaction between leucine and the 
methyl group of the N-acetylated moiety on C2 on 
UDP-GlcNAc from the human enzyme seems to be 
disrupted in CjGne by the replacement with valine, 
thereby resulting in a larger reduction in conversion 
activity of the acetylated substrates. Methionine is 
similar in size to leucine and the L294M mutation 
had similar levels of activity for both non-acety-
lated and acetylated substrates except for UDP-Glc-
NAc. In all cases, the epimerization is much less ef-
ficient than that catalyzed by the wild type. For the 
L294Y mutant, the bulky side chain of tyrosine 
likely reduced the active site volume, thus leading 
to the highest loss of epimerization with UDP-Gal-
NAc. Taken together, we showed the variants of 
single active site residue (L294) could alter sub-
strate specificity, although the previously predicted 
pattern did not fit here.  
 
Lastly, the inhibition of CjGne by ebselen provides 
evidence for this as a small molecule target, but eb-
selen itself is not a likely route as it has been re-
ported to target myriads of biological pathways 
(50). It will be important to find inhibitors that are 
specific to CjGne. The search for such inhibitors is 
ongoing. 
 
In conclusion, based on a high-resolution 
CjGne/NAD+ crystal structure and biochemical 
data from mutants, we proposed some critical resi-
dues of CjGne that are catalytically or structurally 
important. These findings along with its observed 
susceptibility to a HsGalE inhibitor, suggest a route 
for antibiotic development. 
 
 
Experimental procedures 
 
Materials and chemicals  
 
Genomic DNA of C. jejuni NCTC11168 
(#700819D-5) was purchased from ATCC (Manas-
sas, VA). Two constructs of HsGalE with either N-
terminal (pET28a vector) or C-terminal (pET31B 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted September 22, 2020. . https://doi.org/10.1101/2020.09.22.308395doi: bioRxiv preprint 
 8	
	
vector) hexahistidine (His6) tags were kindly pro-
vided by the Holden Group at the University of 
Wisconsin, Madison. The former was used for ca-
pillary electrophoresis and the latter was used for 
stability assays, each described below. E. coli 
NiCo21(DE3) competent cells were obtained from 
New England Biolabs Inc. (Ipswich, MA). UDP-
Glucose, UDP-Galactose, UDP-GlcNAc, UDP-
GalNAc, nicotinamide adenine dinucleotide 
(NAD+), dithiothreitol (DTT), tris (2-carboxyethyl) 
phosphine (TCEP), and bovine serum albumin 
(BSA) were from Sigma-Aldrich (St. Louis, MO). 
Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-
one) was from Cayman Chemical (Ann Arbor, MI).  
 
Cloning of gne  
 
The plasmid encoding gne (cj1131c) of C. jejuni 
was constructed by one-step enzymatic DNA as-
sembly through Gibson cloning (51). Briefly, the 
gne gene and the plasmid for insertion were ampli-
fied from genomic DNA of C. jejuni NCTC11168 
and a pET33b-derived vector, respectively, using 
primers with ca. 40 bp of homology to each other. 
5 µL of DNA sample (0.7 µL of the amplified gne 
gene (10 ng/µL) plus 4.3 µL of the amplified vector 
(10 ng/µL )) was added to 15 µL of a master mix 
solution including T5 exonuclease, Phusion DNA 
polymerase and Taq DNA ligase, then incubated at 
50°C for 60 min. To avoid self-colonies from the 
template-vector, the PCR product amplified from 
the vector was treated with DpnI. The final con-
struct contained a N-terminal His6-tag followed by 
a thrombin cleavage site (N-MGG-
SHHHHHHGLVPRGS-gne-C). All DNA con-
structs were confirmed by sequencing. 
 
Generation of point mutations  
 
All mutations, including T122V, N176L, L294V, 
L294M, L294Y, C181A, C181S, C328S, ΔC328, 
C181S-ΔC328, C196A (HsGalE), and C196S 
(HsGalE) were prepared in a mixture solution con-
taining Phusion® High-Fidelity PCR Master Mix 
with HF Buffer from New England Biolabs Inc. 
(Ipswich, MA), the DNA template of the QK45AA 
mutant (based on the surface entropy reduction pre-
diction (52)), and primers with or without 5% 
DMSO (53). The recommended PCR protocol for 
using the Phusion® HF PCR MM from NEB Inc. 
was used.  
Expression and purification of CjGne 
 
Constructs were transformed and expressed in E. 
coli NiCo21(DE3) strain that are originally derived 
from BL21(DE3). Cells were grown in cultures of 
2xYT with kanamycin (35 µg/mL) to an optical 
density of OD600 0.5-0.7, then induced with 0.4 mM 
isopropyl b-D-thiogalactoside (IPTG, Anatrace, 
Maumee, OH) at 37°C for 6 h. Cells were harvested 
by centrifugation (4,000 rpm, 20 min, 4°C), resus-
pended in lysis buffer (20 mM Tris-HCl, pH 7.5, 
100 mM NaCl, 1 mM DTT), and lysed by three 
passes through a microfluidizer (18 kpsi), and cen-
trifuged at 12,000 rpm for 20 min at 4°C. Proteins 
were purified from the supernatant by nickel affin-
ity chromatography followed by size exclusion 
chromatography. Briefly, the cell lysate was modi-
fied to 10 mM imidazole then passed through a 1 
mL pre-equilibrated Ni-NTA agarose resin (Qi-
agen, Germantown, MD), washed with 30x column 
volumes of 20 mM imidazole-containing buffer, 
then eluted with 20 mL of 250 mM imidazole-con-
taining buffer. The elution was concentrated using 
a 10-kD cut-off Amicon® Ultra-4 Centrifugal Filter 
(Millipore) and further purified by either a Super-
dex-200 16/60 or Superdex-200 10/300 gel-chro-
matography column (GE Healthcare, Little Chal-
font, UK). The fractionated protein was concen-
trated again using the Amicon® Centrifugal Filter, 
flash frozen, and stored at -80°C. In all cases, point 
mutants behaved similar to wild-type during purifi-
cation. 
 
Size exclusion chromatography and multi-angle 
laser light scattering (SEC-MALLS) 
 
Purified protein was analyzed by SEC-MALLS 
(Wyatt Technology, Santa Barbara, CA). Briefly, a 
Shodex KW-804 column (Showa Denko America, 
Inc., New York, NY) was equilibrated in running 
buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 
10% glycerol, 10 mM bME). 100 µg of either BSA 
as a standard or CjGne were injected and run at 0.5 
mL/min for 30 min. Data analysis was performed 
using Astro 5.3.4 software. For the sample run, 
peaks from LS, dRI, and UV (280 nm) detectors 
were aligned by defining baseline and applying 
band broadening values from the BSA run.  
 
Crystallization of CjGne and x-ray diffraction  
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For crystallization, the purified QK45AA opti-
mized variant of CjGne was pre-incubated with 5 
mM UDP-GlcNAc at 4°C overnight. Crystalliza-
tion screening was performed by sitting drop vapor-
diffusion with commercially available screens 
(Hampton Research, Qiagen, Emerald BioSystems) 
and then incubated at room temperature. Initial con-
ditions were refined by additive screening using the 
Additive ScreenTM (Hampton Research). The final 
drop consisted of 0.2 µL of mother liquor (1.3 M 
sodium acetate trihydrate (pH 7.0) with 50 mM so-
dium malonate) and 0.2 µL of protein (16-20 
mg/mL). Crystals grew to full-size after several 
days. For cryo-protection, crystals were transferred 
to a drop containing 70% reservoir solution and 
30% glycerol for 5 sec then flash frozen in liquid 
nitrogen. Diffraction data were collected from a sin-
gle crystal at beamline 12-2 at the Stanford Syn-
chrotron Radiation Lightsource (SSRL). Despite 
numerous attempts, we were never able to obtain 
crystals of our point-mutants with or without the 
QK45AA mutation. 
 
Structural determination and refinement  
 
Images were collected on a Dectris Pilatus 6M pixel 
detector. Diffraction data were integrated with XDS 
(54) and scaled with SCALA in CCP4 (55). Crys-
tals were in the space group P41212 with unit cell 
dimensions a=b=87.7 c=261.66 and a complete 
dataset was collected to 2.0 Å. The asymmetric unit 
contained two copies of CjGne (residues 2-328), 
two NAD+, two acetate, seven glycerol, and 167 
water molecules. Phases were obtained by molecu-
lar replacement using the structure of UDP-Glc 4-
epimerase from Bacillus Anthracis as a search 
model (PDB entry: 2C20; 42% identity) in Phaser 
as implemented in Phenix (56, 57). Manual model 
building was performed using Coot (58). CjGne 
was refined in Phenix with final R-factor of 19.5% 
(Rfree = 22.5%). Statistics for data collection and 
structure determination are found in Table 1. 
 
Epimerization assay using capillary electropho-
resis  
 
Enzyme reactions were performed in 100 μL of re-
action mixture containing 50 mM Tris-HCl (pH 
8.0), 1 mM of UDP-sugar, 1 mM of NAD+, and 50 
ng of CjGne at 37°C. The reaction was stopped af-
ter 24 hours by boiling for 5 min and then centri-
fuged (12,000 rpm, 20 min) to remove protein ag-
gregates. In the case of the inhibition assay with eb-
selen, enzyme reactions were prepared in 20 μL 
containing 50 mM Tris-HCl (pH 8.0), a 1 mM of 
UDP-sugar, 1 mM of NAD+, 50 ng of CjGne, and 
100 µM ebselen at 37°C for 24 hours. The reactions 
were then stopped by boiling for 5 min and centri-
fuged. The samples were monitored using a HP 
3DCE capillary electrophoresis instrument 
equipped with a UV-VIS diode-array detector 
(DAD) (Agilent Technologies, Santa Clara, CA, 
USA). The 50 cm-long capillary was packed with 
fused silica and the running buffer was 20 mM so-
dium tetraborate decahydrate, pH 9 (J.T. Baker®, 
Avantor Performance Materials, Center Valley, 
PA). The capillary was preconditioned for each run 
by washing with the running buffer for 2 min. Each 
sample was injected by pressure of 50 mbar for 10 
sec and the separation was performed at 30 kV and 
detected at 260 nm (330 nm as background). The 
average retention times for UDP-Glc, UDP-Gal, 
UDP-GlcNAc, and UDP-GalNAc were 8.7 min, 8.9 
min, 8.3 min, and 8.5 min, respectively. The peak 
area was estimated and integrated using the soft-
ware 3D-CE Chemstation Rev. A.09.03.  
 
Standard deviations (𝜎𝜎!) for the normalized conver-
sion values in Table 2 and Figures 5-7 were calcu-
lated based on the equation below (𝑥𝑥": mean raw 
conversion value for mutant; 𝑦𝑦": mean raw conver-
sion value for wild type; 𝜎𝜎#: standard deviation of 
raw conversion value for mutant; 𝜎𝜎$: standard de-
viation of raw conversion value for wild type). 
 
𝑧𝑧" =
𝑥𝑥"
𝑦𝑦"
, 𝜎𝜎! = 𝑧𝑧"	()
𝜎𝜎#
𝑥𝑥"
*
%
+ )
𝜎𝜎$
𝑦𝑦"
*
%
 
 
A fluorescence-based thermal shift assay   
 
The thermal shift assay was based on Niesen et al 
(59). A real-time PCR device (CFX96 from Bio-
Rad, Hercules, CA) was used to monitor protein un-
folding through fluorescence by SYPRO Orange 
(Sigma-Aldrich, St. Louis, MO) at 2x concentration 
(1:2,500 dilution of 5,000x stock). Fluorescence 
(λex 470 nm/ λem 570 nm) was measured using the 
filter sets found on the real-time PCR instrument. 
Protein samples (2 μM) in 20 mM Tris buffer (pH 
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7.5) containing 100 mM NaCl, 1 mM NAD+, 1mM 
DTT, 1mM of a UDP-sugar substrate in a reaction 
volume of 50 μL were mixed in 96-well PCR plates 
(Bio-Rad, Hercules, CA). The plates were briefly 
spun down at 1,000 rpm and placed in the device. 
Melting curves were measured starting with a 15-
minute pre-chilling at 15°C then increased in 0.5°C 
steps to 95°C with 30 second incubation. The fluo-
rescence intensity at the end of each step is plotted 
as a function of temperature. The resulting sig-
moidal curve was best fit to a two-state transition. 
The inflection point of the melting curve, melting 
temperature (Tm), was calculated using the internal 
PCR software.  
 
Data Availability: The structure presented in this 
paper has been deposited in the Protein Data Bank 
(PDB) with the following code: 7K3P. All remain-
ing data are contained within the article.  
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Table 1. Statistics of x-ray data collection and refinement.  
	
Data collection 
Space group P41 21 2 
Cell dimensions 
     a/b/c (Å) 87.7/ 87.7/ 261.66 
     α/β/γ (°) 90/ 90/ 90 
Resolution (Å)a 65.42–2.04 (2.09–2.04) 
Rmerge a 0.052 (0.677) 
I/σ (I) a 18.0 (2.4) 
Completeness (%)a 99.9 (100) 
Redundancy a 6.6 (6.8) 
Refinement 
Resolution (Å) 62.0 – 2.0 
No. reflections 65,906 
Rwork/ Rfree 19.5/ 22.5 
No. atoms 5,463 
     Protein 5,290 
     Ligand/ion 6 
     Water  167 
Mean B-factor 38.1 
RMSb deviations 
     Bond lengths (Å) 0.008 
     Bond angles (°) 1.1 
                    a Values in parentheses are for highest-resolution shell 
                       b RMS, root mean square 
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Table 2. Average percent conversion values and their standard deviations of the substrates by CjGne and 
HsGalE. The protein samples include the wild type (WT) and mutants. Ebselen, an inhibitor, was added 
only to CjGne. The normalized mean and standard deviation of percent conversion values of UDP-hexose 
substrates are shown (See Experimental procedures for the normalized standard deviation calculation).  
 
Enzymes UDP-Glc UDP-Gal UDP-GlcNAc UDP-GalNAc 
raw normalized raw normalized raw normalized raw normalized 
CjGne 
(WT) 
23.2 ± 0.2 100.0 ± 1.2 75.3 ± 1.0 100.0 ± 1.9 27.7 ± 0.2 100.0 ± 1.1 71.4 ± 0.7 100.0 ± 1.4 
C181A 1.7 ± 0.5 7.5 ± 2.1   0.6 ± 0.3 0.7 ± 0.4 5.8 ± 0.2 20.8 ± 0.7 1.4 ± 1.2 2.0 ± 1.7 
C181S 1.2 ± 0.1 5.3 ± 0.5 1.0 ± 0.4 1.4 ± 0.5 6.1 ± 0.5 22.1 ± 1.9 0.9 ± 0.8 1.3 ± 1.1 
C328S 8.8 ± 3.2 37.9 ± 13.8 10.6 ± 3.9 14.0 ± 5.2 9.4 ± 0.4 34.0 ± 1.5 14.4 ± 3.3 20.1 ± 4.6 
ΔC328 23.6 ± 0.2 101.9 ± 1.2 76.0 ± 0.3 100.9 ± 1.4 27.5 ± 0.1 99.3 ± 0.9 72.1 ± 0.7 100.9 ± 1.4 
C181S/ 
ΔC328 
1.1 ± 0.5 4.8 ± 2.3 0.6 ± 0.3 0.8 ± 0.4 5.9 ± 0.2 21.4 ± 0.9 0.7 ± 0.6 0.9 ± 0.8 
T122Vc 0 ± 0 0 ± 0 0 ± 0 0 ± 0 4.5 ± 2.9 16.3 ± 10.3 0 ± 0 0 ± 0 
N176La 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 
L294Vc 11.4 ± 5.2 49.4 ± 22.5 40.7 ± 11.9 54.0 ± 15.8 10.8 ± 2.0 39.0 ± 7.2 10.5 ± 6.9 14.7 ± 9.7 
L294Mc 2.7 ± 2.3 11.8 ± 9.7 12.1 ± 5.8 16.1 ± 7.7 12.1 ± 2.1 43.8 ± 7.5 12.5 ± 8.5 17.4 ± 11.9 
L294Yc 2.4 ± 3.5 10.4 ± 15.3 10.6 ± 7.4 14.1 ± 9.9 5.8 ± 0.7 20.8 ± 2.5 0.4 ± 1.0 0.6 ± 1.4 
WT +  
ebselen 
2.9 ± 1.8 12.6 ± 7.8  1.5 ± 2.1 2.0 ± 2.7 6.1 ± 0.1 22.0 ± 0.5 0 ± 0b 0 ± 0 
HsGalE 
(WT) 
25.2 ± 1.0 100.0 ± 5.7 72.6 ± 0.6 100.0 ± 1.2 23.3 ± 1.4 100.0 ± 8.5 56.3 ± 5.9 100.0 ± 14.9 
C196A 25.1 ± 1.1 99.8 ± 5.9 62.8 ± 4.0 86.5 ± 5.6 18.9 ± 3.0 81.3 ± 13.9 47.9 ± 3.1 85.1 ± 10.5 
C196S 25.7 ± 1.2 102.2 ± 6.4 68.4 ± 1.4 94.2 ± 2.1 19.7 ± 1.1 84.8 ± 6.9 52.0 ± 4.7 92.4 ± 12.8 
The a, b, and c refers to a single, duplicate, and quintuplicate measurement, respectively. The rest of the values are from triplicates.  
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Table 3. Average melting temperatures (°C) and their standard deviations of the wild type (WT) and mu-
tants of CjGne and HsGalE*.   
 
Enzymes Melting Temperature (°C) 
UDP-Glc UDP-Gal UDP-GlcNAc UDP-GalNAc 
CjGne (WT) 57.0  57.2 ± 0.3 58.5  58.0  
C181A 49.3 ± 0.3 49.5  51.3 ± 0.3 50.5  
C181S 50.8 ± 0.3 50.7 ± 0.3 53.0 ± 0.5 51.5  
C328S 54.5  54.2 ± 0.3 55.5  55.0  
ΔC328 52.5  52.0 53.8 ± 0.6 52.5  
C181S/ΔC328 49.3 ± 0.3 49.5 50.2 ± 0.3 50.2 ± 0.3 
HsGalE (WT) 59.0 59.0a 59.0 59.0 
C196A 59.0 59.0 59.0 59.0 
C196S 59.0 ± 0.2 59.0 59.0 n.d. 
      The a refers to a single measurement. The rest of the values are from at least duplicates.  
      * Standard deviations of zero are not shown. 
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Figures  
 
 
Figure 1. The 2.0Å crystal structure of CjGne in complex with NAD+. A. A catalytic reaction scheme of 
CjGne involving four substrates, UDP-Glc, UDP-Gal, UDP-GlcNAc, UDP-GalNAc, and 4-ketose interme-
diate. B. (Top) An asymmetric unit contains two molecules of CjGne with a two-fold symmetry. (Bottom) 
The two molecules are rotated by 90°. In both cases, a monomer in the cartoon representation is colored 
with rainbow; N-terminus is with red and C-terminus is with blue. One NAD+ molecule in each monomer 
is shown in stick representation with the purple backbone. C. The SEC-MALLS result shows CjGne forms 
a dimer (~72 kDa; blue) in solution as compared to the bovine serum albumin (BSA) standard (monomer: 
~60 kDa; dimer: ~128 kDa; red). D. A monomer is colored the same as in Figure 1B. Additionally, the 
disulfide bond is depicted in yellow spheres. NBD and SBD are also labeled.  
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Figure 2. NAD+ and NBD. A. Comparison of the chemical structures of NAD+ and NADH. The only 
difference lies in the nicotinamide ring, depicted as a R group. B. On the left, the 2Fo-Fc map that is refined 
with NAD+ is shown in mesh at 2 s and the magnified view of the nicotinamide ring. On the right, the Fo-
Fc map that is refined with NADH is shown in mesh at 3 s. C. On the left, a monomer of CjGne in the 
same orientation as in Figure 1D is colored grey. NAD+ is shown in stick representation and its backbone 
is purple. Ile82 is indicated by a red arrow. On the right, this is a magnified view of the NBD. The residues 
that are in a hydrogen-bonding distance to adenosine, phosphates, and nicotinamide/ribose are shown in 
stick representation and colored orange, blue, and green, respectively. The residues that interact with NAD+ 
via backbone are bolded (Tyr11, Ile12, Lys35, and Leu57). Hydrogen bonds are shown in black dashed 
lines. 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted September 22, 2020. . https://doi.org/10.1101/2020.09.22.308395doi: bioRxiv preprint 
 20	
	
 										 
 
Figure 3. SBD of CjGne. A CjGne monomer is shown in complex with NAD+ and UDP-GlcNAc from 
HsGalE (PDB ID: 1HZJ). A. Aligned CjGne (slate) and the HsGalE SBD (green cyan) in the box region. 
Y190, P191, R287, and D290 of CjGne and R300 and D303 of HsGalE are shown in stick representation. 
B. Same region as in Figure 3A, but only HsGalE is shown along with the polar contacts in black dashed 
lines. C. Same region as in Figure 3A, but CjGne and UDP-GlcNAc from HsGalE are shown with polar 
contacts in black dashed lines. D. Same region as in Figure 3A, but only CjGne is shown with polar contacts 
between R287/D290 and Y190/P191. 
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Figure 4. Unique features of CjGne. A. Structural alignment between CjGne/NAD+ (slate) and 
HsGalE/NADH/UDP-GlcNAc (PDB ID: 1HZJ) (green cyan). The SBD is magnified in the box. NAD+, 
NADH, and UDP-GlcNAc are shown in the stick representation. C181 and C328 of CjGne along with the 
disulfide bond and C196 of HsGalE are also in the stick representation. B. The full length of CjGne. C. 
Multiple sequence alignment of Campylobacterales using ClustalX 2.1 (60). Only two alignment regions 
(Y174-L195 and D312-C328; CjGne numbering) that are highlighted in the sequence scheme in figure 4B 
are shown. The background coloring is as follows: aromatic (cyan), hydrophobic (blue), polar (green), gly-
cines (orange), negative charge (purple), positive charge (red), prolines (yellow), and unconserved (white). 
D. A phylogenetic tree of the Campylobacterales was drawn in NJplot (61). E. Multiple sequence alignment 
of CjGne and its homologs using ClustalX 2.1 (60). The alignment with only the region from Y174 to L195 
(CjGne numbering) is shown here. The sequences that are used here are, from the top, Gne from Campylo-
bacter jejuni, GalE from Homo sapiens, GalE from Escherichia coli, GalE from Trypanosoma brucei, 
WbpP from Pseudomonas aeruginosa, GalE from Thermotoga maritima, and GalE from Pyrobaculum ca-
lidifontis. The color scheme is the same as in Figure 4C. Please see Supplementary Figure 1 for the full-
length multiple sequence alignment. 
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Figure 5. Epimerization assays of the wild type and cysteine mutants of CjGne and HsGalE. A. An example 
of the % conversion of UDP-Glc to UDP-Gal by CjGne measured in capillary electrophoresis. The equation 
used to calculate % conversion is provided in the box. B. The results of % conversion of each of four 
substrates by CjGne. Each reaction was repeated for three times and the error bars indicate the standard 
deviations. C. Normalized % conversion of UDP-GlcNAc by the wild type and cysteine mutants of CjGne 
(slate) and HsGalE (green cyan). Each reaction was repeated for three times and the error bars are the 
standard deviations (See Experimental procedures for the normalized standard deviation calculation). D. 
The melting temperature values (Tm) of the wild type and cysteine mutants of CjGne (slate) and HsGalE 
(green cyan) in the presence of UDP-Glc. Each measurement was repeated for three times and the error 
bars indicate the standard deviations.   
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Figure 6. Predicted active site of the CjGne/NAD+ complex. A. On the left, structural alignment between 
CjGne/NAD+ and UDP-GlcNAc from the HsGalE/NADH/UDP-GlcNAc (PDB ID: 1HZJ). In the center, 
the putative active site of CjGne is magnified with T122, N176, and L294 labeled. On the right, the catalytic 
site of HsGalE is magnified to the same extent as that with CjGne with S132, N187, and C307 labeled. 
Hydrogen bonds are indicated as black dashes. B. Normalized % conversion of UDP-Glc, UDP-Gal, UDP-
GlcNAc, and UDP-GalNAc by the wild type and catalytic mutants of CjGne. Each reaction was repeated 
for five times except for N176L only for once. The error bars are the standard deviations (See Experimental 
procedures for the normalized standard deviation calculation).  
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Figure 7. Inhibition of CjGne by ebselen. Chemical structure of ebselen is shown in the top right corner. 
Each inhibition reaction was repeated for three times except for the one with UDP-GalNAc only for twice. 
The error bars are the standard deviations (See Experimental procedures for the normalized standard 
deviation calculations). 
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Supplementary Figure 1. Multiple sequence alignment of the full-length CjGne and its homologs using 
ClustalX 2.1 (60). The sequences aligned are the same as in Figure 4E. The background coloring is the 
same as in Figure 4C and 4E. The numbers on the right indicate the last residue number of each segment of 
protein sequences. The numbers on the top of the segments, except for 196*, indicate the CjGne residues 
that are mentioned in this work. 196* indicates the cysteine residue in HsGalE.    
 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted September 22, 2020. . https://doi.org/10.1101/2020.09.22.308395doi: bioRxiv preprint 
